Anthera Pharmaceuticals Enterprise Value:
86.33M for May 17, 2013Anthera Pharmaceuticals Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 86.33M |
| May 16, 2013 | 82.16M |
| May 15, 2013 | 82.16M |
| May 14, 2013 | 86.66M |
| May 13, 2013 | 80.67M |
| May 10, 2013 | 79.33M |
| May 9, 2013 | 79.94M |
| May 8, 2013 | 82.16M |
| May 7, 2013 | 77.71M |
| May 6, 2013 | 74.74M |
| May 3, 2013 | 75.34M |
| May 2, 2013 | 76.20M |
| May 1, 2013 | 76.95M |
| April 30, 2013 | 77.71M |
| April 29, 2013 | 80.22M |
| April 26, 2013 | 79.96M |
| April 25, 2013 | 82.68M |
| April 24, 2013 | 83.65M |
| April 23, 2013 | 82.90M |
| April 22, 2013 | 84.38M |
| April 19, 2013 | 88.06M |
| April 18, 2013 | 83.62M |
| April 17, 2013 | 83.47M |
| April 16, 2013 | 85.58M |
| April 15, 2013 | 87.37M |
| April 12, 2013 | 90.02M |
| April 11, 2013 | 90.80M |
| April 10, 2013 | 90.33M |
| April 9, 2013 | 90.80M |
| April 8, 2013 | 92.58M |
| April 5, 2013 | 91.09M |
| April 4, 2013 | 92.58M |
| April 3, 2013 | 92.52M |
| April 2, 2013 | 92.58M |
| April 1, 2013 | 93.33M |
| March 28, 2013 | 94.07M |
| March 27, 2013 | 91.09M |
| March 26, 2013 | 92.58M |
| March 25, 2013 | 91.09M |
| March 22, 2013 | 93.94M |
| March 21, 2013 | 89.60M |
| March 20, 2013 | 92.45M |
| March 19, 2013 | 91.09M |
| March 18, 2013 | 46.93M |
| March 15, 2013 | 46.61M |
| March 14, 2013 | 47.25M |
| March 13, 2013 | 45.27M |
| March 12, 2013 | 46.60M |
| March 11, 2013 | 44.87M |
| March 8, 2013 | 44.58M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
ANTH Enterprise Value Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 165.75B |
| Pfizer | 213.40B |
| Tetraphase Pharmaceuticals | 165.21M |
ANTH Enterprise Value Rankings
| Overall |
53rd percentile 3549 of 7593 |
| Sector |
39th percentile 394 of 650 in Healthcare |
| Industry |
44th percentile 29 of 52 in Drug Manufacturers - Major |
ANTH Enterprise Value Range, Past 5 Years
| Minimum | 8.234M | Jun 29 2012 |
| Maximum | 296.37M | Feb 3 2012 |
| Average | 116.68M |
